| scholarly article | Q13442814 |
| P356 | DOI | 10.1001/ARCHNEUR.55.9.1248 |
| P698 | PubMed publication ID | 9740120 |
| P2093 | author name string | Sharma OP | |
| P433 | issue | 9 | |
| P921 | main subject | hydroxychloroquine | Q421094 |
| chloroquine | Q422438 | ||
| P304 | page(s) | 1248-1254 | |
| P577 | publication date | 1998-09-01 | |
| P1433 | published in | Archives of Neurology | Q15766672 |
| P1476 | title | Effectiveness of chloroquine and hydroxychloroquine in treating selected patients with sarcoidosis with neurological involvement | |
| P478 | volume | 55 |
| Q92083058 | A Brief Overview of the Antitumoral Actions of Leelamine |
| Q34604474 | Antimalarials in cutaneous lupus erythematosus: mechanisms of therapeutic benefit |
| Q38179076 | Approaches to the treatment of some of the troublesome manifestations of sarcoidosis |
| Q47142375 | Case report: middle-aged woman from Ghana with unsteady gait and enlarging cerebellar mass |
| Q38732080 | Characteristics and Long-Term Outcome of Neurosarcoidosis: A Population-Based Study from 1976-2013. |
| Q53513808 | Clinical aspects and immune reactions in sarcoidosis. |
| Q54218397 | Current and Future Use of Chloroquine and Hydroxychloroquine in Infectious, Immune, Neoplastic, and Neurological Diseases: A Mini-Review. |
| Q34636680 | Current and emerging strategies for the management of sarcoidosis |
| Q33750289 | Disorders that mimic central nervous system infections |
| Q41919048 | Effect of hydroxychloroquine on progression of dementia in early Alzheimer's disease: an 18-month randomised, double-blind, placebo-controlled study |
| Q73181344 | End-stage renal disease in sarcoidosis of the kidney |
| Q36119381 | Fungal infections as a complication of therapy for sarcoidosis |
| Q34300297 | Granulomatous disease in CVID: retrospective analysis of clinical characteristics and treatment efficacy in a cohort of 59 patients |
| Q35729575 | Immune mediated diseases and immune modulation in the neurocritical care unit |
| Q24245305 | Immunosuppressive and cytotoxic therapy for pulmonary sarcoidosis |
| Q36262452 | Inflammatory neuropathies: an update on evaluation and treatment |
| Q46271418 | Infliximab for the treatment of CNS sarcoidosis: A multi-institutional series |
| Q38049882 | Intramedullary spinal sarcoidosis masquerading as cervical stenosis |
| Q34728782 | Isolated neurosarcoidosis--a diagnostic enigma: case report and discussion |
| Q30308416 | Neurologic manifestations of sarcoidosis |
| Q56600644 | Neurosarcoidosis |
| Q74582968 | Neurosarcoidosis |
| Q80184825 | Neurosarcoidosis |
| Q86847144 | Neurosarcoidosis |
| Q41761173 | Neurosarcoidosis presenting as a cerebellar mass |
| Q35811051 | Neurosarcoidosis: a clinical dilemma |
| Q35621134 | Neurosarcoidosis: diagnosis, therapy and biomarkers |
| Q90327245 | New insights on the antiviral effects of chloroquine against coronavirus: what to expect for COVID-19? |
| Q37309116 | Orofacial presentations of sarcoidosis--a case series and review of the literature |
| Q35627655 | Pharmacotherapeutic management of pulmonary sarcoidosis |
| Q43595679 | Sarcoidosis |
| Q54152750 | Sarcoidosis |
| Q42793583 | Sarcoidosis of the pineal gland: an unusual presentation of neurosarcoidosis |
| Q36507399 | Sarcoidosis of the spinal cord: literature review and report of eight cases |
| Q42837361 | Systemic Sarcoidosis Presenting with Headache and Stroke-Like Episodes |
| Q37856272 | Systemic treatment of sarcoidosis |
| Q41917013 | Therapeutic options in neurosarcoidosis |
| Q80202594 | [Neurosarcoidosis treated with mycophenolate mofetil: two cases] |
| Q79411734 | [Neurosarcoidosis] |
| Q64885870 | [Subacute myelopathy revealing systemic sarcoidosis] |
Search more.